A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

NCT00909597 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

756

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: pioglitazone
DRUG: taspoglutide
DRUG: taspoglutide

Sponsor

Hoffmann-La Roche